Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Ultrasound-guided Radiofrequency Ablation in the Treatment of Refractory Hyperthyroidism

NCT06305871 is registered in ClinicalTrials.gov with Zhang Bo as lead sponsor.

NCT NCT06305871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06305871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Ultrasound-guided Radiofrequency Ablation in the Treatment of Refractory Hyperthyroidism
Lead sponsor
Zhang Bo
Phase
Not applicable
Overall status
Unknown status
Start date
August 1, 2023
Completion date
July 31, 2025
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperthyroidism/thyrotoxicosis